News

Filter

Current filters:

PharmaceuticalOphthalmics

1 to 9 of 109 results

ThromboGenics announces positive data from 24-month followup study of Jetrea

ThromboGenics announces positive data from 24-month followup study of Jetrea

24-03-2015

Ophthalmic medicine specialist ThromboGenics has announced positive top-line results from its study of…

JetreaOphthalmicsPharmaceuticalResearchThromboGenics

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

11-03-2015

Biopharma company Ocular Therapeutix has announced positive top-line data from the first of two Phase…

Ocular TherapeutixOphthalmicsPharmaceuticalResearchUSA

Nicox makes reserved capital increase of $29.6 million for 15 million new shares

Nicox makes reserved capital increase of $29.6 million for 15 million new shares

06-03-2015

French ophthalmic company Nicox has made a reserved capital increase of ordinary shares to specific categories…

FinancialFranceNicOxOphthalmicsPharmaceutical

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

20-02-2015

The UK’s National Institutes of Health and Care Excellence has recommended Ozurdex (dexamethasone),…

AllerganDexamethasoneOphthalmicsOzurdexPharmaceuticalRegulationUK

NICE gives green light to Bayer’s Eylea for DME

20-02-2015

In a preliminary recommendation issued today, England’s health costs watchdog the National Institute…

BayerEyleaOphthalmicsPharmaceuticalPricingRegulationUK

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

19-02-2015

US biotech Regeneron Pharmaceuticals today announced results from a study which show Eylea (aflibercept)…

AvastinEyleaLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsResearchUSA

Use of generics key to glaucoma medicine adherence, study says

Use of generics key to glaucoma medicine adherence, study says

18-02-2015

A potential solution to resolve patient non-adherence in glaucoma treatment is switching to generic drugs,…

Bimatoprost Ophthalmic Solution 0.03% for GlaLatanoprost OphthalmicOphthalmicsPharmaceuticalPricingResearchUSA

FDA approves Alcon's Pazeo for ocular allergy itch relief

FDA approves Alcon's Pazeo for ocular allergy itch relief

02-02-2015

The US Food and Drug Administration has approved Pazeo (olopatadine hydrochloride ophthalmic solution)…

AlconHealthHealth Medical PharmaNovartisOlopatadine hydrochlorideOphthalmicsPharmaceuticalUSA

1 to 9 of 109 results

Back to top